Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

140
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
140
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

134
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
134
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

283
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Revisiting Turing's Chemical Basis of Morphogenesis.

Bulletin of mathematical biology·2026
Same author

Revisiting Turing's Chemical Basis of Morphogenesis.

Bulletin of mathematical biology·2026
Same author

Optogenetic control of transition to metamorphosis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Béla Novák (1956-2025) - a legacy of scientific discovery and personal charm.

Journal of cell science·2025
Same author

Stochastic Boolean model of normal and aberrant cell cycles in budding yeast.

NPJ systems biology and applications·2024
Same author

Newton's cradle: Cell cycle regulation by two mutually inhibitory oscillators.

Mathematical biosciences·2024
Same journal

Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Pediatric oral cavity physiologically based pharmacokinetic model to predict pharmacokinetics of mucoadhesive atropine gel to treat sialorrhea.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial.

Journal of pharmacokinetics and pharmacodynamics·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.0K

Understanding virtual patients efficiently and rigorously by combining machine learning with dynamical modelling.

Tongli Zhang1, John J Tyson2

  • 1Department of Pharmacology & Systems Physiology, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45219, USA. zhangtl@ucmail.uc.edu.

Journal of Pharmacokinetics and Pharmacodynamics
|January 5, 2022
PubMed
Summary
This summary is machine-generated.

Quantitative systems pharmacology (QSP) uses virtual patients (VPs) to model population heterogeneity. This study introduces a machine learning and bifurcation analysis pipeline to effectively analyze VP behaviors and gain mechanistic insights.

Keywords:
Bifurcation analysisHypothalamic–pituitary–adrenal axisMachine learningNonlinear dynamicsQuantitative systems pharmacologyVirtual patients

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.0K
Photorealistic Learned Landscapes for Augmented Reality
06:54

Photorealistic Learned Landscapes for Augmented Reality

Published on: June 27, 2025

254

Related Experiment Videos

Last Updated: Oct 7, 2025

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.0K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.0K
Photorealistic Learned Landscapes for Augmented Reality
06:54

Photorealistic Learned Landscapes for Augmented Reality

Published on: June 27, 2025

254

Area of Science:

  • Pharmacology
  • Computational Biology
  • Systems Biology

Background:

  • Biological systems exhibit significant heterogeneity, challenging single-model population descriptions.
  • Quantitative Systems Pharmacology (QSP) utilizes virtual patients (VPs) to represent patient population variability.
  • Analyzing complex VP populations requires advanced computational methods.

Purpose of the Study:

  • To present an integrated pipeline combining machine learning (ML) and bifurcation analysis for efficient VP population analysis.
  • To demonstrate how this pipeline can uncover mechanistic insights into system behaviors driven by parameter variations.
  • To advocate for the broader adoption of this pipeline in systems pharmacology.

Main Methods:

  • Development of an integrated computational pipeline.
  • Application of machine learning (ML) for analyzing multi-parameter contributions in VP populations.
  • Utilization of bifurcation analysis to provide mechanistic understanding of system dynamics.

Main Results:

  • The ML-ML and bifurcation analysis pipeline effectively analyzes VP behaviors.
  • ML captures contributions of simultaneous parameter changes, surpassing local sensitivity analyses.
  • Bifurcation analysis provides rigorous mechanistic insights into parameter influences on system dynamics.

Conclusions:

  • The proposed pipeline offers an effective and efficient method for analyzing virtual patient populations.
  • This approach facilitates a deeper understanding of patient heterogeneity in systems pharmacology.
  • Wider adoption of this pipeline can advance the practical application of VPs in drug development and research.